Blue Jet Healthcare Limited
Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products. It provides contrast media intermediates; niche pharmaceutical intermediates and APIs; and CDMO/CMO services, as well as end-to-end solutions from process development and commercialization of NCEs, advance… Read more
Blue Jet Healthcare Limited (BLUEJET) - Total Liabilities
Latest total liabilities as of September 2025: ₹2.72 Billion INR
Based on the latest financial reports, Blue Jet Healthcare Limited (BLUEJET) has total liabilities worth ₹2.72 Billion INR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Blue Jet Healthcare Limited - Total Liabilities Trend (2020–2025)
This chart illustrates how Blue Jet Healthcare Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Blue Jet Healthcare Limited Competitors by Total Liabilities
The table below lists competitors of Blue Jet Healthcare Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Nordfyns Bank A/S
CO:NRDF
|
Denmark | Dkr5.00 Billion |
|
NOCIL Limited
NSE:NOCIL
|
India | ₹3.01 Billion |
|
Quoc Cuong Gia Lai JSC
VN:QCG
|
Vietnam | ₫4.00 Trillion |
|
Lucky Strike Entertainment Corporation
NYSE:LUCK
|
USA | $3.28 Billion |
|
Vinte Viviendas Integrales S.A.B. de C.V
MX:VINTE
|
Mexico | MX$18.35 Billion |
|
Daiken Biomedical Co., Ltd.
TW:7780
|
Taiwan | NT$304.81 Million |
|
Easy Trip Planners Limited
NSE:EASEMYTRIP
|
India | ₹4.04 Billion |
|
Acme United Corporation
NYSE MKT:ACU
|
USA | $57.28 Million |
Liability Composition Analysis (2020–2025)
This chart breaks down Blue Jet Healthcare Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.11 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.22 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.18 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Blue Jet Healthcare Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Blue Jet Healthcare Limited (2020–2025)
The table below shows the annual total liabilities of Blue Jet Healthcare Limited from 2020 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | ₹2.84 Billion | +33.14% |
| 2024-03-31 | ₹2.14 Billion | +18.30% |
| 2023-03-31 | ₹1.81 Billion | -5.87% |
| 2022-03-31 | ₹1.92 Billion | -2.35% |
| 2021-03-31 | ₹1.96 Billion | +13.79% |
| 2020-03-31 | ₹1.73 Billion | -- |